Research Type: Academic Literature

Academic literature is reviewed by peer experts in a scientific field before it is approved for publication. The acceptance of our opinions and research after this vetting process indicates its relevance to current policies and other important drug and device issues.

  • What A Waste! The National Academy Of Medicine’s Report On Oversized Vials Of Expensive Drugs

  • Value-Based Management of Specialty Drugs: Practical Considerations and Implications for Pharmacy

  • CMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing of Drugs

  • Priceless Knowledge: Attitudes and Awareness Around Drug Pricing Among US Medical Students

  • Who Is Sowing Seeds of Confusion About The QALY?

  • Pharmaceutical Products and Their Value: Lessons Learned and the Path Ahead

  • DPL, Commonwealth Fund and Health Affairs Release Policy Papers

  • US Drug Prices And R&D, Take 2: A Reply To Grabowski And Manning, And To Light

  • Eli Lilly Announces Additional Vial Size to Minimize Waste

  • Dr. Peter Bach Explains How Increasing Drug Prices Stifles Innovation